RED HERRING: Not an offer to invest. Professional Investors, Qualified Institutional Buyers, Accredited Investors, by Invitation only.

Vaccines & Immunity

Summary:
As of April 8, 2020, CEPI reports 115 vaccine candidates are in varying stages of development, 78 of which are confirmed as active and 37 are unconfirmed. To end the COVID-19 Pandemic safe and effective vaccines will be required for the entire global population. Estimated requirement: 5 billion doses.
Published for educational purposes and social benefit, not for profit. Not a recommendation or endorsement. Always consult your doctor for medical advice.

October 2020

September 2020

COVAX: CEPI’s response to COVID-19

2020-09-19T14:00:20+00:00September 19th, 2020|

CEPI, Gavi and the WHO have launched COVAX to ensure equitable access to COVID-19 vaccines and end the acute phase of the pandemic by the end of 2021. The Scale [...]

JAMA | COVID-19 and the Path to Immunity

2020-10-11T12:08:48+00:00September 11th, 2020|

Reprinted for educational purposes and social benefit, not for profit.  The emergence of adaptive immunity in response to the novel Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurs within [...]